WHO recommends biannual HIV prevention shots amid funding concerns
|
WHO urges global use of new twice-yearly HIV
prevention shot, citing its impact on infections despite concerns over
long-term funding. |
HIV-1 Vaccine Shows Strong T-Cell Response in Phase 1 Study
The experimental HIV vaccine regimen exhibited an acceptable safety profile and elicited robust immune responses in 99% of trial participants from ... View article...